Copertina

Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Aarti Bhatia, Ranee Mehra, Jessica Bauman, Saad A. Khan, Wei Wei, Veronique Neumeister, Teresa Sandoval‐Schaefer, R. Katherine Alpaugh, Miriam Lango, David L. Rimm, John A. Ridge, Barbara Burtness
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Head & Neck
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
di: Hiromasa Ishihara, et al.
Pubblicazione: (2025)

Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4 /6 Pathway
di: Joo‐Hwan Park, et al.
Pubblicazione: (2026)

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study
di: Alizée Simon, et al.
Pubblicazione: (2025)

Correction to “Snail Controls the Mesenchymal Phenotype and Drives Erlotinib Resistance in Oral Epithelial and Head and Neck Squamous Cell Carcinoma Cells”
Pubblicazione: (2024)

Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early‐Stage Squamous Cell Carcinoma of the Head and Neck: Long‐Term Follow‐Up
di: Pauline Kim, et al.
Pubblicazione: (2025)

A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD ‐1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
di: Mathias Fiedler, et al.
Pubblicazione: (2026)

Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
di: Nikhil Bellamkonda, et al.
Pubblicazione: (2024)

Safety and Efficacy Findings From a Phase Ib/ II Study of ASP ‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
di: David M. Cognetti, et al.
Pubblicazione: (2025)

Impact of Extranodal Extension in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta‐Analysis
di: Andrea Costantino, et al.
Pubblicazione: (2025)

Impact of Prior Neck Treatment Status on Salvage Treatment Outcomes in Isolated Regional Recurrence of Head and Neck Squamous Cell Carcinoma
di: Younghac Kim, et al.
Pubblicazione: (2025)

Response to Letter to the Editor: Fully COVID ‐19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
di: Chien‐Chung Wang, et al.
Pubblicazione: (2026)

Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma
di: Chao Yang, et al.
Pubblicazione: (2025)

Association of Socioeconomic Factors and Immunotherapy in Cutaneous Squamous Cell Carcinoma of the Head and Neck
di: Christie Hung, et al.
Pubblicazione: (2026)

Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency
di: Brejjette Aljabi, et al.
Pubblicazione: (2025)

The Burden of Recurrent Head and Neck Squamous Cell Carcinoma Across the United Kingdom: Results From a National Snapshot Study
di: Andrew Williamson, et al.
Pubblicazione: (2024)

Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma
di: Jade Saykaly, et al.
Pubblicazione: (2026)

Examining the Interaction Between Sex and Race in Outcomes of Head and Neck Squamous Cell Carcinoma
di: Geena Jung, et al.
Pubblicazione: (2025)

Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma
di: Abdullah A. Adil, et al.
Pubblicazione: (2026)

Impact of Extranodal Extension in Patients With Regional Metastases of Head and Neck Cutaneous Squamous Cell Carcinoma
di: Rachel Braude, et al.
Pubblicazione: (2026)

Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas
di: Sandhya Kalavacherla, et al.
Pubblicazione: (2025)

History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma
di: Mitsuhiko Katoh, et al.
Pubblicazione: (2026)

Cigarette Smoke Exposure Attenuates T2R ‐Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma
di: Kyle Polen, et al.
Pubblicazione: (2026)

The Role of Multicancer Early Detection Tests in Head and Neck Squamous Cell Carcinoma: A Case Series
di: Abhinav Talwar, et al.
Pubblicazione: (2026)

Altered Bacteria Abundance Is Associated With Outcomes in Head and Neck Squamous Cell Carcinoma
di: Delaney H. Sheehan, et al.
Pubblicazione: (2025)

Diffusion‐Weighted MRI for Recurrent/Persistent Head and Neck Squamous‐Cell Carcinoma After Radiotherapy: Systematic Review and Meta‐Analysis
di: Luca Canali, et al.
Pubblicazione: (2024)

Persistent Opioid Use Following Resection of Oral Cavity Squamous Cell Carcinoma: Incidence and Risk Factors
di: Cameron C. Lee, et al.
Pubblicazione: (2025)

Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary
di: Robin W. Jansen, et al.
Pubblicazione: (2025)

The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts
di: Pranit R. Sunkara, et al.
Pubblicazione: (2024)

Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma
di: Seo Yoon Jang, et al.
Pubblicazione: (2025)

Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis
di: Rohan Vuppala, et al.
Pubblicazione: (2025)

Detection of Circulating Cancer‐Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma and Their Impact on Circulating Tumor Cells
di: Kazuaki Chikamatsu, et al.
Pubblicazione: (2025)

Prediction and Prognostication of Peripheral Blood Biomarkers in Head and Neck Cutaneous Squamous Cell Carcinoma
di: Mikayla G. Hubbard, et al.
Pubblicazione: (2026)

Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study
di: Ryosuke Sato, et al.
Pubblicazione: (2025)

Aspirin Use and Head and Neck Cancer
di: Shih‐Wei Lai
Pubblicazione: (2024)

Inflammatory Markers‐Based Surgical Pathological Complete Response Prediction After Neoadjuvant Immunotherapy Combined With Chemotherapy in Head and Neck Squamous Cell Carcinoma
di: Yu‐Dong Ning, et al.
Pubblicazione: (2026)

A Real‐World Phase IV Superiority Trial and Cost‐Effectiveness Analysis of the Addition of Low‐Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients
di: Avinash Khadela, et al.
Pubblicazione: (2025)

EpCAM‐Targeted Erlotinib Delivery: Enhancing Nasopharyngeal Carcinoma Treatment With Polyethylene Glycol‐Coated Graphene Oxide
di: Chien‐Fu Yeh, et al.
Pubblicazione: (2025)

Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma
di: Kevin L. Li, et al.
Pubblicazione: (2025)

Early and Long‐Term Thyroid Dysfunction in Patients With Head and Neck Squamous Cell Carcinoma After External Radiotherapy: Clinicopathological Risk Factors
di: Adriana Russo Fiore, et al.
Pubblicazione: (2025)

Variations in Treatment Prescription and Survival Outcomes Between Older and Younger Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy
di: Farhannah Aly, et al.
Pubblicazione: (2026)